Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy

Publisher： Karger

E-ISSN： 2296-5262|38|11|560-569

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.11, 2015-0, pp. : 560-569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Survival in a Smoking Caucasian Male Patient Treated with Gefitinib for Spinal Cord Compression Secondary to Lung Cancer

By  

Oncology Research and Treatment, Vol. 34, Iss. 6, 2011-05 ,pp. : 326-328

Karger

Access to resources Recommend Favorite

Afatinib, Erlotinib and Gefitinib in the First-Line Therapy of EGFR Mutation-Positive Lung Adenocarcinoma: A Review

By  

Oncology Research and Treatment, Vol. 36, Iss. 9, 2013-08 ,pp. : 510-518

Karger

Access to resources Recommend Favorite

Bone Mineral Density Response to Long-Term Bisphosphonate Therapy in Fibrous Dysplasia

By Parisi M.S.   Oliveri M.B.   Gómez Acotto C.   Mautalen C.A.  

Journal of Clinical Densitometry, Vol. 4, Iss. 2, 2001-03 ,pp. : 167-172

Humana Press, Inc

Access to resources Recommend Favorite

Flt3L Therapy following Localized Tumor Irradiation Generates Long-Term Protective Immune Response in Metastatic Lung Cancer: Its Implication in Designing a Vaccination Strategy

By  

Oncology, Vol. 70, Iss. 4, 2006-10 ,pp. : 245-254

Karger

Access to resources Recommend Favorite

Polymerase Domain B Mutation Is Associated with Hepatitis Relapse during Long-Term Lamivudine Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 48, Iss. 6, 2005-07 ,pp. : 381-388

Karger

Access to resources Recommend Favorite